Drug Trial Radar · NCT05383183
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Mar 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
630
Planned (sponsor's estimate)
Start
Jan 20, 2022
Primary completion
Jun 30, 2025
Study completion Dec 9, 2025
Sponsor
- Lead sponsor
- Daewoong Bio Inc.Industry
- Sponsor type
- Industry
- First posted
- May 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether combination of donepezil, a cholinesterase inhibitor, with choline alfoscerate has a more favourable clinical profile than monotherapy with donepezil alone.
Conditions
- Alzheimer Disease
Interventions
Choline Alfoscerate 400mgDrug
Oral administration
PlaceboDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in ADAS-Cog scoresTime frame: 48 weeks from baseline
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Changwon Fatima Hospital
Changwon, South Korea · Recruiting
Gachon University Gil Medical Center
Incheon, South Korea · Recruiting
CHA Bundang Medical Center
Seongnam, South Korea · Recruiting
The Catholic University of Korea Seoul ST.MARY'S Hospital
Seoul, South Korea · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.